FDA finalizes COVID-era guidance on container closure changes
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyCBERCDERChemistry, Manufacturing and Controls (CMC)Coronavirus/COVID-19PharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicySterile drugsSupply Chain ManagementUnited States